Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or in Combination in Recurrent/Metastatic Cervical or HPV+ Head & Neck Cancer
ID Number 15-0955Principal Investigator(s)
Department(s) or Division(s)
Hematology and Medical Oncology
The sponsor of this study Advaxis, Inc. has begun a research study of two investigational products called ADXS11-001 and MEDI4736 as possible therapies for cervical cancer or human papilloma virus (HPV) induced squamous cell cancer of the head and neck. An investigational product is one which has not been approved by the United States Food and Drug Administration.
Recruiting Patients: Yes